Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 3Recruiting 2Not yet recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Neoplasms 8Prostatic Neoplasms 7Leukemia, Myeloid, Acute 6Colorectal Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Congenital Abnormalities 4Pancreatic Neoplasms 3Multiple Myeloma 3Lymphoma, Mantle-Cell 3Lung Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Venous Thromboembolism 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Papillomavirus Infections 2Neuroblastoma 2Neoplasm Metastasis 2Motor Activity 2Melanoma 2Lymphoma, Follicular 2Lymphoma 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2

Interventions

Sorafenib 121Nivolumab 36pembrolizumab 32lenvatinib 27Bevacizumab 27Doxorubicin 23Radiosurgery 21Radiofrequency Ablation 20Oxaliplatin 20Hepatectomy 18Fluorouracil 15Capecitabine 15Magnetic Resonance Spectroscopy 14atezolizumab 13Leucovorin 13Cisplatin 13Gemcitabine 11Erlotinib Hydrochloride 11tislelizumab 9Sirolimus 9Radiotherapy 9Irinotecan 9Ipilimumab 9cabozantinib 8Liver Transplantation 8regorafenib 7Ramucirumab 7Folfox protocol 7Embolization, Therapeutic 7sintilimab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Carcinoma, Hepatocellular × Observation × Clear all
NCT06637059 2024-10-15

Artificially Intelligent Model for Accurate Detection of HCC

Zhejiang University

Completed
1,092 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02109146 2024-05-29

Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma

Zhejiang University

Phase 3 Completed
332 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00759109 2017-04-07

Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)

Merck Sharp & Dohme LLC

Phase 3 Completed
150 enrolled 12 charts
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡